공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

질량분석 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년)

Mass Spectrometry Market - Growth, Trends, Covid-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 03월 상품 코드 391377
페이지 정보 영문
가격
US $ 4,250 ₩ 4,788,000 PDF (Single User License)
US $ 4,750 ₩ 5,352,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 6,760,000 PDF (Site License)
US $ 7,500 ₩ 8,451,000 PDF (Corporate License)


질량분석 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년) Mass Spectrometry Market - Growth, Trends, Covid-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 03월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

질량분석(MS)은 질량대 전하비와 기상식 이온의 존재도 측정에 의해 샘플내 화학제품의 양과 종류를 식별하는 분석화학 기술입니다. 질량분석 시장은 사용하는 기술 또는 플랫폼에 기반하여 분류되며, 싱글 질량분석, 하이브리드 또는 이중질량분석 및 기타 질량분석법으로 나뉩니다. 이 부문 중에서도 하이브리드 질량분석은 폭넓게 적용되며 다른 플랫폼에 비해 가장 높은 시장점유율을 차지합니다. 트리플 4중극, 이온 트랩, Q-TOF와 FT-MS를 포함한 LC-MS 기술의 과거 5년간 기술 혁신은 혁명적이며, 연구자에게 이전보다 증가한 시장 수요에 기여하는 훨씬 상세한 정보를 얻기 위한 툴을 제공하고 있습니다.

세계의 질량분석 시장을 조사했으며, 전체적인 시장 동향, 제품·지역별 상세 동향, 시장 성장에 대한 영향요인 분석, 경쟁 구도, 주요 기업 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

  • 구제책 연구
  • 시장의 정의
  • 수량 단위
  • 기본 통화
  • 리뷰와 예보 기간 연도
  • 조사의 일반적인 전제조건

제2장 조사 방법

  • 서론
  • 분석 방법론
  • 계량 경제학적 예측 모델
  • 조사의 전제조건

제3장 개요

제4장 주요 추론

제5장 시장 개요 및 산업 동향

  • 현재 시장 시나리오
  • 기술 개요
  • 치료제의 새로운 개발
  • 투자 분석
  • Porter의 산업 분석
    • 공급업체의 교섭력
    • 바이어의 교섭력
    • 경쟁 정도
    • 대체품의 위협
    • 신규 참여업체의 위협

제6장 성장요인, 저해요인, 기회 및 과제 분석(DROC)

  • 시장 성장요인
    • 생명과학 연구에서 정부지출의 증가
    • 제약 업계의 연구개발비 증가
    • 식품 및 음료 업계에서 높아지는 식품에 대한 관심
  • 시장 저해요인
    • 설비 비용
    • 숙련 노동자의 결여
  • 시장 기회
    • 수중 미량 오염물질 모니터링
    • 프로테오믹스
    • 기능 게노믹스
  • 주요 과제

제7장 시장 세분화

  • 기술별
    • 싱글 질량분석
    • 하이브리드 질량분석
  • 제품별
    • 설비
    • 시약 및 소모품
    • 서비스
  • 애플리케이션별
    • 의약품
    • 바이오테크놀러지
    • 산업 화학
    • 환경 시험
    • 식품 및 음료 시험
    • 의학 연구

제8장 지역별 시장 : 지역별 점유율 및 예측

  • 북미
    • 서론
    • 미국
    • 캐나다
    • 기타
  • 유럽
    • 서론
    • 프랑스
    • 영국
    • 독일
    • 스페인
    • 러시아
    • 이탈리아
    • 기타
  • 아시아태평양
    • 서론
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 기타
  • 중동·아프리카 지역
    • 서론
    • 아랍에미리트
    • 사우디아라비아
    • 이스라엘
    • 기타 MEA 국가
  • 중남미
    • 서론
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타

제9장 경쟁 구도

제10장 주요 벤더

  • Agilent Technologies
  • Danaher Corporation
  • PerkinElmer Inc
  • Thermo Fisher Scientific
  • Bruker Corporation
  • Waters Corporation
  • Shimadzu Corporation.
  • Leco Corporation.
  • Dani Instruments S.P.A.

제11장 애널리스트에 의한 투자 기회 전망

제12장 시장 전망

제13장 부록

  • 약어
  • 참고 문헌
  • 면책사항
KSA 18.03.12

The mass spectrometry market registered a market size of USD 4,880 million in 2020 and expected to grow USD 7,301 million by 2026 with a CAGR of nearly 6.3% during the forecast period. Certain factors that are driving the market growth include the increasing technological advancement, growing concerns over food safety, and rising R&D expenditure by the pharmaceutical industry and government research organizations.

It is one of the powerful tools used for the analyses of chemical and biological entities. In addition, high demand from the biotechnology and pharmaceutical industries due to COVID-19 are driving factors for mass spectrometry market. In 2020, in India, researchers at the Delhi-based Institute of Genomics and Integrative Biology (IGIB) and the National Centre for Disease Control (NCDC) have been able to detect novel coronavirus (COVID-19) with 95% sensitivity and 100% specificity with respect to RT-PCR using mass spectrometer.

According to the Organisation for Economic Co-operation and Development (OECD), in 2018, in Germany, approximately 3.13% of GDP was spent on research and development which was increased from 3.07% of GDP in 2017 and 2.94% of GDP in 2016, respectively. Increasing investment on research and development activities is expected to increase demand for mass spectrometer in the drug development, proteomics and pharmaceuticals and drives the market growth.

Furthermore, advancements in mass spectroscopy technology were able to increase the factors like rapid test results with high resolution. The discovery of new tools has the potential to stimulate the usage of mass spectroscopy across drug development, pharmaceuticals, food safety testing, proteomics and other fields.

The demands of the life sciences applications have led to the improvement of mass spectrometry technologies. The mass spectrometry such as MALDI-ToF used as a clinical diagnostic platform utilising a highly advanced method of protein pattern recognition to diagnose diseases. Hence, with the increasing technological advancement, the market is expected to grow over the forecast period.

Key Market Trends

Triple Quadrupole (Tandem) is Expected to Hold Significant Market Share in the Type of Hybrid Mass Spectrometry

Currently the tandem mass spectrometry devices are among the most in-demand. Liquid chromatography-mass spectrometry (LC-MS/MS)-based approaches are considered reagent-free. The high sensitivity and specificity of mass spectrometry can overcome many limitations associated with immunoassays such as cross-reactivity and non-specific antibody binding.

There is a higher demand for triple quadrupole mass spectrometer because triple quadrupole mass spectrometr is considered one of the most high-end instruments and moreover, many labs across the world are adopting this instrument.

For instance, according to a research article by Malin Kallsten et al., published in Analytical and Bioanalytical Chemistry Journal 2019, there has been a trend in mass spectrometry based characterization of antibody-drug conjugates (ADCs) towards the use of high-resolving mass spectrometry for many of these analyses. Quadrupole mass spectrometers represent a viable alternative for the characterization of antibody-drug conjugates (ADCs) in early-stage drug development.

As per Patented Medicine Prices Review Board 2018 report, in 2018, total R&D spending by the pharmaceutical industry was around 0.89 billion Canadian dollars which was increased from 0.87 billion Canadian dollars in 2017. Thus, increasing R&D spending on pharmaceuticals is expected to rise demand for mass spectrometrs in near future.

Moreover, a United Kingdom biotech laboratory has used mass spectrometry for coronavirus testing. In April 2020, United Kingdom diagnostics firm, MAP Sciences announced the development of rapid test for the COVID-19 virus. This technology deploys mass spectrometry to spot proteins that are unique to COVID-19 and is targeting to deliver test results within 30 minutes. These advancements are expected to fuel the growth of the studied market.

North America is Expected to Hold Major Market Share Over the Forecast Period

The major factors driving the market growth in North America region include growing funding for research and government initiatives in the United States, widespread usage of mass spectrometry in the metabolomics and petroleum sector and presence of key market players.

The United States government spends a significant percentage of its GDP on R&D. According to a 2018 report published by the Organization for Economic Co-operation and Development (OECD), about 2.82% of the country's GDP was spent on R&D. In addition, in 2019, the research and development (R&D) expenditure of U.S. pharmaceutical industry was around USD 83 billion up from USD 79.6 billion in 2018 and USD 71.4 billion in 2017, respectively. Thus, increasing R&D activities increase demand for mass spectrometers and drives market growth.

Drug development is an expensive and lengthy process, and the failure rate is also high. Factors such as lengthy-time period, high failure rate and high cost are forcing researchers to look for newer technologies.

Additionally, mass spectroscopy is also being used in clinical laboratories to measure small sample volumes, with improved confidence across an expanding range of healthcare applications, from toxicology to personalized medicine.

As per a September 2020 article, published in Oxford Academics, states that in the United States, response to the coronavirus disease-19 pandemic has been hampered by inadequate testing resources. Therefore, technologies such as, matrix-assisted laser desorption/ionization combined with mass spectrometry (MALDI-MS) are used to provide faster and cheaper diagnosis, which may drive its demand, over the forecast period.

Competitive Landscape

The Mass Spectrometry Market is highly competitive. The leading players offer an expansive product portfolio for mass spectrometers and have a broad geographic presence. Companies like Agilent Technologies, Bruker Corporation, Danaher Corporation, Dani instruments s.p.a, Leco Corporation, Perkin Elmer Inc., Shimadzu Corporation, Thermo Fisher Scientific, and Waters Corporation, among others, hold the substantial market share in the mass spectrometry market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Technological Advancement
    • 4.2.2 Growing Concerns Over Food Safety
    • 4.2.3 Rising R&D Expenditure By Pharmaceutical Industry & Government Research Organizations
  • 4.3 Market Restraints
    • 4.3.1 High Cost Of Instrument
    • 4.3.2 Lack Of Skilled Technicians
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Hybrid Mass Spectrometry
      • 5.1.1.1 Triple Quadrupole (Tandem)
      • 5.1.1.2 Quadrupole TOF (Q-TOF)
      • 5.1.1.3 FTMS (Fourier Transform Mass Spectrometry)
    • 5.1.2 Single Mass Spectrometry
      • 5.1.2.1 ION Trap
      • 5.1.2.2 Quadrupole
      • 5.1.2.3 Time-of-Flight (TOF)
    • 5.1.3 Other Mass Spectrometry
  • 5.2 By Application
    • 5.2.1 Pharmaceuticals Industry
    • 5.2.2 Biotechnology Industry
    • 5.2.3 Chemical Industry
    • 5.2.4 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies
    • 6.1.2 Bruker Corporation
    • 6.1.3 Danaher Corporation
    • 6.1.4 MassTech
    • 6.1.5 Analytik Jena (Endress+Hauser)
    • 6.1.6 Perkin elmer Inc.
    • 6.1.7 Shimadzu Corporation
    • 6.1.8 Thermo Fisher Scientific
    • 6.1.9 Waters Corporation
    • 6.1.10 JEOL Ltd.
    • 6.1.11 FLIR Systems, Inc.
    • 6.1.12 MKS Instruments, Inc.
    • 6.1.13 Hiden Analytical
    • 6.1.14 DANI Instruments S.p.A.
    • 6.1.15 LECO Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q